Scout | Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)

This grant offers researchers the opportunity to request support for preclinical services to help develop products aimed at advancing promising treatments for HIV and related co-infections like Hepatitis B, Hepatitis C, and Tuberculosis. It is available to both academic and private institutions.

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Allergy and Infectious Diseases

Program: SBIR

Dates

Opportunity Released: May 27, 2022

Open for Submission: May 27, 2022

Submission Deadline: January 17, 2025

Application Window Closes: January 17, 2025

Keywords

HIV

preclinical services

product development

therapeutics

Hepatitis B

Hepatitis C

Tuberculosis

academic institutions

private institutions

gap filling

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers